![Hsing I Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hsing I Chen began roles at Elixiron Immunotherapeutics (Cayman) Ltd. and PharmaEssentia Corp.
in 2025.
At Elixiron Immunotherapeutics (Cayman) Ltd., the role is Independent Director starting in 2025.
At PharmaEssentia Corp., the role is Chief Legal Officer starting in 2025.
Both roles are current.
| Società | Posizione | Inizio |
|---|---|---|
| ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED | Direttore/Membro del Consiglio | 23/10/2025 |
| PHARMAESSENTIA CORPORATION | Consigliere Generale | 09/05/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
PharmaEssentia Corp.
 PharmaEssentia Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutic products for the treatment of hematologic diseases | Health Technology |
Elixiron Immunotherapeutics, Inc.
 Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision immunotherapy drugs | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
